Stories

कंपनी साल 2026 के अंत तक इसके बड़े पैमाने पर क्लीनिकल ट्रायल शुरू करने की योजना बना रही है, और अगले दो सालों में इसे बाजार में लाने की उम्मीद है.Image : AI
N
News18•26-09-2026, 13:36
Revolutionary Male Birth Control: 2 New Options, PausePill & Plan A, Set to Transform Family Planning
  • •For centuries, family planning responsibility has largely fallen on women, but now men are getting two new contraceptive options.
  • •A global survey reveals 61% of men are ready to use new male contraceptives, with 49% in the US showing interest.
  • •NEXT Life Sciences is developing two key products: PausePill, an on-demand oral contraceptive, and Plan A, a long-acting reversible implant.
  • •PausePill is a non-hormonal pill that interferes with sperm release during ejaculation; early trials showed 100% efficacy.
  • •Plan A is a reversible implant using Vasalgel technology, injecting a hydrogel into the vas deferens, which can later be dissolved to restore fertility.

Key Questions Answered

The company 'NEXT Life Sciences' is developing two primary products for male contraception: 'PausePill', a non-hormonal oral contraceptive to be used when needed, and 'Plan A', a long-acting reversible implant.

PausePill is a non-hormonal oral contraceptive that interferes with the biological signal instructing sperm to be released during ejaculation without stopping overall sperm production or negatively affecting physical capacity, erection, or orgasm.

Plan A involves injecting a special hydrogel into the vas deferens during a quick 10-minute clinic procedure without incisions or stitches, acting as a flexible barrier to block sperm while allowing fluids to pass normally, and it can later be dissolved to restore fertility.